James Caruso V bought $25k of CLRB
Chief Executive Officer at Cellectar Biosciences, Inc.. 8,680 shares at an average of $2.88, traded May 7, 2026, filed May 11, 2026.
Score components
- +25RoleCEO
- 0Trade size$25k at market
- +10Relative to holdingsHoldings up 75%
- +8Price context76% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -26.1%, 3m -15.0%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-058851, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 7, 2026 | POpen-market purchase Common Stock | +8,680 | $2.88 | $25k | 20,318 | May 11, 2026 |
| May 7, 2026 | POpen-market purchase Warrantsderivative | +26,040 | $0.01 | $260 | 36,076 | May 11, 2026 |
Related signals
Other insiders at Cellectar Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | Cellectar Biosciences, Inc. | Jarrod Longcor Chief Operating Officer | $25k 8,680 shares | +74% | |
| 35Weak | CLRBsell Cellectar Biosciences, Inc. | John Neis director | $732 198 shares | -95% | |
| 75Notable | Cellectar Biosciences, Inc. | James Caruso V Chief Executive Officer | $50k 10,000 shares | +611% | |
| 65Notable | Cellectar Biosciences, Inc. | Chad J Kolean Chief Financial Officer | $25k 5,000 shares | +353% | |
| 70Notable | Cellectar Biosciences, Inc. | Jarrod Longcor Chief Operating Officer | $50k 10,000 shares | +361% | |
| 30Weak | CLRBbuy Cellectar Biosciences, Inc. | Jarrod Longcor Chief Operating Officer | $8,400 30,000 shares | +56% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.